Skip to main content
IMDX
NASDAQ Life Sciences

Cash-Strapped iMDx Launches Public Offering With Stock at 52-Week Low

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.84
Mkt Cap
$60.867M
52W Low
$1.85
52W High
$7.92
52W Position info
0.5% below low
Off High info
77% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

IMDX is trading near its 52-week low of $1.85 (0.5% below the low).

Summary

iMDx kicked off an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole bookrunner and a 30-day option for up to 15% more shares. No size or pricing was disclosed, so the dilution overhang is open-ended until terms print. The timing is rough: the stock closed at $1.84, essentially at its 52-week low of $1.85, and the company just reported a Q2 loss of $11.3M on $239K of revenue with $17.8M in cash and a going-concern flag. Proceeds are earmarked for working capital and R&D in the transplantation category, which is where the GraftAssureDx FDA decision sits. This follows the September 8-K amending the Chronix merger agreement to replace the ongoing 10% CNI Monit obligation — another sign of balance-sheet pressure.

At the time of this announcement, IMDX was trading at $1.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $60.9M. The 52-week trading range was $1.85 to $7.92. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

IMDX - Latest Insights

IMDX
Aug 10, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.72
Real-time Price: $1.50 info
Change: -$3.22 (-68%) info
Market Cap: $60.867M info
IMDX
Aug 10, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.72
Real-time Price: $1.50 info
Change: -$3.22 (-68%) info
Market Cap: $60.867M info
IMDX
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.72
Real-time Price: $1.50 info
Change: -$3.22 (-68%) info
Market Cap: $60.867M info
IMDX
Jul 16, 2026, 3:22 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.63
Real-time Price: $1.50 info
Change: -$3.13 (-68%) info
Market Cap: $60.867M info
IMDX
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.32
Real-time Price: $1.50 info
Change: -$3.82 (-72%) info
Market Cap: $60.867M info